featured
TNF-α Inhibitors Improve Insulin Sensitivity in Psoriasis Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cutaneous Medicine for the Practitioner
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of Tumor Necrosis Factor α Inhibitors Extend Beyond Psoriasis: Insulin Sensitivity in Psoriasis Patients With Type 2 Diabetes Mellitus
Cutis 2016 Mar 01;97(3)235-241, N Al-Mutairi, D ShabaanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.